PMID: 8948304Nov 1, 1996Paper

Intravenous immunoglobulin as sole therapy for systemic vasculitis

British Journal of Rheumatology
D R Jayne, C M Lockwood

Abstract

High-dose, pooled, i.v. immunoglobulin (IVIg) is a potential, alternative treatment for Wegener's granulomatosis (WG) and microscopic polyangiitis (MPA) which has shown promise in the treatment of refractory disease when administered with continuing immunosuppression. This study of six new patients with antineutrophil cytoplasmic antibody (ANCA)-positive vasculitis and early disease, without threatened vital organ function, examined the therapeutic response to treatment with IVIg alone. IVIg was well tolerated and all six patients had early reductions in disease activity. Four entered full, clinical remission which lasted for at least 1 yr, while in two the responses were partial and transient, and they subsequently required conventional treatment. After 16-48 months of follow-up, two of the four patients in full remission relapsed, but the other two have remained well.

Citations

Nov 4, 2004·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Priya J Bansal, Mary C Tobin
Feb 8, 2006·The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland·A M KhanD R Ingrams
Jun 14, 2014·Current Rheumatology Reports·Loïc Guillevin
Dec 21, 2000·Current Rheumatology Reports·D K Ledford
Sep 27, 2000·Annals of the Rheumatic Diseases·C AuzaryJ C Piette
Jun 26, 2003·Arthritis Research & Therapy·Carol A Langford
Nov 18, 2004·Annals of the Rheumatic Diseases·M G DanieliG Danieli
Dec 17, 2008·Current Opinion in Rheumatology·Sharon A Chung, Philip Seo
Jul 11, 2009·Clinical Reviews in Allergy & Immunology·Shaye KivityYehuda Shoenfeld
Oct 10, 2001·Springer Seminars in Immunopathology·D Jayne
Mar 14, 2007·Journal of Clinical Immunology·Vir-Singh NegiSrini V Kaveri
Sep 26, 2006·Journal of Neurology·Andreas Steinbrecher, Peter Berlit
Mar 10, 2006·European Journal of Pediatrics·Michael J Dillon
Feb 25, 2010·Rheumatology·Prashantha M Vaitla, Elizabeth M McDermott
Jan 5, 2002·Expert Opinion on Investigational Drugs·C Thomas-Golbanov, S Sridharan
Jun 5, 2003·Expert Opinion on Biological Therapy·Anthony D BoothDavid R W Jayne
Mar 9, 2010·La Presse médicale·Loïc Guillevin
Apr 7, 2009·Journal of Autoimmunity·J U Holle, W L Gross
Sep 24, 2005·Clinical and Experimental Immunology·S JollesS A Misbah
Apr 24, 2004·Journal of the Peripheral Nervous System : JPNS·Yusuf A RajaballyRichard J Abbott
Jun 1, 2001·Acta Clinica Belgica·L Guillevin
Nov 1, 2007·Dermatologic Therapy·Anthony P Fernandez, Francisco A Kerdel
Nov 4, 2009·Clinical and Experimental Immunology·H-P HartungS Jolles
Mar 24, 2016·Biomolecules·Ana Filipa Barahona Afonso, Cristina Maria Pires João
Dec 28, 2006·Journal of the American Academy of Dermatology·David I SmithMichael P Heffernan
Apr 29, 2005·Best Practice & Research. Clinical Rheumatology·David Jayne
Nov 4, 2005·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Nagio TakigawaKiyoshi Takahashi
Mar 31, 2015·Autoimmunity Reviews·Giacomo Maria GuidelliAntonella Fioravanti
Apr 15, 2015·Autoimmunity Reviews·Nurit Katz-AgranovGisele Zandman-Goddard
Jul 11, 2000·Rheumatology·D Jayne
May 17, 2018·Drugs·Loïc Raffray, Loïc Guillevin
Aug 26, 2006·Nature Clinical Practice. Rheumatology·Peter K Wung, John H Stone
Apr 12, 2007·Clinical Reviews in Allergy & Immunology·Loïc GuillevinLuc Mouthon
Jan 5, 2008·Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology·Tomoki OriguchiKatsumi Eguchi
Dec 19, 2006·Seminars in Cutaneous Medicine and Surgery·Mary Jo J KernsMichael P Heffernan
Apr 27, 2007·Allergology International : Official Journal of the Japanese Society of Allergology·Loïc Guillevin, Christian Pagnoux
May 19, 2009·Expert Opinion on Pharmacotherapy·Marian Chan, Raashid Luqmani
Apr 23, 2003·Current Opinion in Rheumatology·Yolanda Braun-Moscovici, Daniel E Furst

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
I WatsonP J Garrett
Dermatology : International Journal for Clinical and Investigative Dermatology
H MiyoshiK Katsu
© 2021 Meta ULC. All rights reserved